Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - ALNYLAM PHARMACEUTICALS, INC. | alny-ex322_47.htm |
| EX-32.1 - EX-32.1 - ALNYLAM PHARMACEUTICALS, INC. | alny-ex321_48.htm |
| EX-31.2 - EX-31.2 - ALNYLAM PHARMACEUTICALS, INC. | alny-ex312_49.htm |
| EX-31.1 - EX-31.1 - ALNYLAM PHARMACEUTICALS, INC. | alny-ex311_50.htm |
| EX-23.1 - EX-23.1 - ALNYLAM PHARMACEUTICALS, INC. | alny-ex231_52.htm |
| 10-K - 10-K - ALNYLAM PHARMACEUTICALS, INC. | alny-10k_20171231.htm |
EXHIBIT 21.1
SUBSIDIARIES OF THE REGISTRANT
|
Name |
|
Ownership Percentage |
|
Jurisdiction of Organization |
|
Alnylam U.S., Inc. |
|
100% |
|
Delaware |
|
Alnylam Securities Corporation |
|
100% |
|
Massachusetts |
|
Sirna Therapeutics, Inc. |
|
100% |
|
Delaware |
|
Alnylam (Bermuda) Ltd. |
|
100% |
|
Bermuda |
|
Alnylam Canada ULC |
|
100% |
|
Canada |
|
Alnylam France S.A.S |
|
100% |
|
France |
|
Alnylam Europe AG |
|
100% |
|
Germany |
|
Alnylam Germany GmbH |
|
100% |
|
Germany |
|
Alnylam Italy S.r.l. |
|
100% |
|
Italy |
|
Alnylam Netherlands BV |
|
100% |
|
Netherlands |
|
Alylam Pharmaceuticals Spain SL |
|
100% |
|
Spain |
|
Alnylam Sweden AB |
|
100% |
|
Sweden |
|
Alnylam Switzerland GmbH |
|
100% |
|
Switzerland |
|
Alnylam UK Limited |
|
100% |
|
United Kingdom |